SCHEMBL24994394

SCHEMBL24994394

CCOc1ccc(-c2cnc(Oc3ccccc3)c(C(=O)N/N=C/c3cc(OC)cc(OC)c3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.52
▸ ALDH1A1 P00352 6/20 0.49
▸ HPGD P15428 5/20 0.49
▸ GAA P10253 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ MAPT P10636 6/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ HTT P42858 1/20 0.48
▸ MGAM O43451 2/20 0.47
▸ TP53 P04637 1/20 0.46
▸ NPC1 O15118 3/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ MAOB P27338 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ XBP1 P17861 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24994395 0.91 ALDH1A1 (0.50) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL24993638 0.88 ALDH1A1 (0.52) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL30925925 0.86 ALDH1A1 (0.52) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL24994392 0.85 ALDH1A1 (0.49) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL29215180 0.80 SCN2A (0.57) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL30925931 0.80 SCN2A (0.57) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL29215186 0.80 SCN2A (0.57) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL24993566 0.80 ALDH1A1 (0.49) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL31026509 0.79 ALDH1A1 (0.52) RAB9AALDH1A1HPGDGAACYP1A2
SCHEMBL24993576 0.79 NPC1 (0.50) RAB9AALDH1A1HPGDCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076348-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 — — CN claimed
EP-4382100-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
CN-118076348-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 — — CN disclosed
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback